Alumis Inc. Common Stock
(ALMS - NASDAQ)
24,74 USD
📋 Profilo Aziendale

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

|